当前位置:首页 - 行情中心 - 尚荣医疗(002551) - 财务分析 - 现金流量表

尚荣医疗

(002551)

  

流通市值:21.27亿  总市值:29.42亿
流通股本:6.11亿   总股本:8.45亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金250,704,243.131,138,972,719.88966,709,611.77650,496,729.51
  收到的税费返还10,444,483.2146,453,993.8234,973,658.5923,785,302.21
  收到其他与经营活动有关的现金4,027,656.1444,245,788.2519,289,819.8114,384,743.6
  经营活动现金流入小计265,176,382.481,229,672,501.951,020,973,090.17688,666,775.32
  购买商品、接受劳务支付的现金179,973,795.57710,273,159.76580,433,233.76440,203,123.57
  支付给职工以及为职工支付的现金64,168,403.21263,302,857.89187,353,516.72130,666,389.25
  支付的各项税费11,965,756.2450,110,215.9339,939,200.7930,855,085.19
  支付其他与经营活动有关的现金34,960,248.365,718,737.4294,498,495.6284,962,685.92
  经营活动现金流出小计291,068,203.321,089,404,971902,224,446.89686,687,283.93
  经营活动产生的现金流量净额-25,891,820.84140,267,530.95118,748,643.281,979,491.39
二、投资活动产生的现金流量:
  收回投资收到的现金114,844,245.661,850,176,112.961,353,625,902.111,174,625,902.11
  取得投资收益收到的现金575,053.33-9,394,796.366,192,571.43
  处置固定资产、无形资产和其他长期资产收回的现金净额10,282,00030,685,030.384,001,732.764,001,737.48
  投资活动现金流入小计125,701,298.991,880,861,143.341,367,022,431.231,184,820,211.02
  购建固定资产、无形资产和其他长期资产支付的现金6,061,293.11125,262,604.7417,382,611.3610,952,448.2
  投资支付的现金135,500,0001,772,410,553.261,273,000,000992,000,000
  投资活动现金流出小计141,561,293.111,897,673,1581,290,382,611.361,002,952,448.2
  投资活动产生的现金流量净额-15,859,994.12-16,812,014.6676,639,819.87181,867,762.82
三、筹资活动产生的现金流量:
  取得借款收到的现金10,300,00020,000,00020,000,000-
  收到其他与筹资活动有关的现金289,100.1331,150,00029,200,0001,700,000
  筹资活动现金流入小计10,589,100.1351,150,00049,200,0001,700,000
  偿还债务支付的现金-260,568,902.92292,215,880.09267,215,880.09
  分配股利、利润或偿付利息支付的现金359,333.3322,362,939.369,611,897.082,247,501.66
  支付其他与筹资活动有关的现金67,50060,250,00060,250,00060,250,000
  筹资活动现金流出小计426,833.33343,181,842.28362,077,777.17329,713,381.75
  筹资活动产生的现金流量净额10,162,266.8-292,031,842.28-312,877,777.17-328,013,381.75
四、汇率变动对现金及现金等价物的影响-17,430,667.0211,954,306.18-2,841,438.662,553,446.91
五、现金及现金等价物净增加额-49,020,215.18-156,622,019.81-120,330,752.68-141,612,680.63
  加:期初现金及现金等价物余额297,365,130.41453,987,150.22453,987,150.22453,987,150.22
  期末现金及现金等价物余额248,344,915.23297,365,130.41333,656,397.54312,374,469.59
补充资料:
  净利润--146,208,017.02--4,520,153.56
  资产减值准备-22,038,371.43--10,253.94
  固定资产和投资性房地产折旧-86,856,313.98-43,400,505.39
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-86,856,313.98-43,400,505.39
  无形资产摊销-13,967,140.73-7,363,866.18
  长期待摊费用摊销-857,314.69-788,638.29
  处置固定资产、无形资产和其他长期资产的损失--10,104,229.32-3,104.67
  固定资产报废损失-51,404.99--
  公允价值变动损失--824,808.57-3,638,102.83
  财务费用--7,548,229.02-5,102,165.01
  投资损失--15,284,664.17--7,087,511.07
  递延所得税--12,964,305.67--1,094,371.68
  其中:递延所得税资产减少--12,299,435.1--678,780.71
    递延所得税负债增加--664,870.57--415,590.97
  存货的减少-49,485,601.59-24,852,438.73
  经营性应收项目的减少-74,001,877.58-69,158,862.33
  经营性应付项目的增加-1,641,026.95--122,303,311.68
  现金的期末余额-297,365,130.41-312,374,469.59
  减:现金的期初余额-453,987,150.22-453,987,150.22
  现金及现金等价物的净增加额--156,622,019.81--141,612,680.63
公告日期2026-04-282026-04-282025-10-282025-08-26
审计意见(境内)标准无保留意见
TOP↑